Association of tumor necrosis factor-alpha promoter variants with risk of HPV-associated oral squamous cell carcinoma

Molecular Cancer

Volumn 12, Issue 1, 2013, Pages

  Jin, Lei ^a,b   Sturgis, Erich M ^b   Zhang, Yang ^b,c   Huang, Zhigang ^b,c   Song, Xicheng ^b,d   Li, Chao ^b,e   Wei, Qingyi ^b   Li, Guojun ^b  

^a NANJING UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d YANTAI YUHUANGDING HOSPITAL   (China)

^e SICHUAN CANCER HOSPITAL   (China)

Author keywords

Case control study; HPV infection; Oropharyngeal cancer; Polymorphism; TNF

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CASE CONTROL STUDY; CONTROLLED STUDY; DRINKING BEHAVIOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; OROPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEROLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; WART VIRUS; WILD TYPE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALLELES; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GENETIC VARIATION; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 84880334456     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-12-80     Document Type: Article

References (31)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62:10-29. 10.3322/caac.20138, 22237781.
2. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011, 29:4294-4301. 10.1200/JCO.2011.36.4596, 3221528, 21969503.
3. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Youngman L, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001, 344:1125-1131. 10.1056/NEJM200104123441503, 11297703.
4. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000, 92:709-720. 10.1093/jnci/92.9.709, 10793107.
5. Bachmann A, Hanke B, Zawatzky R, Soto U, van Riggelen J, zur Hausen H, Rosl F. Disturbance of tumor necrosis factor alpha-mediated beta interferon signaling in cervical carcinoma cells. J Virol 2002, 76:280-291. 10.1128/JVI.76.1.280-291.2002, 135709, 11739693.
6. Mocellin S, Nitti D. TNF and cancer: the two sides of the coin. Front Biosci 2008, 13:2774-2783. 10.2741/2884, 17981752.
7. Bequet-Romero M, Lopez-Ocejo O. Angiogenesis modulators expression in culture cell lines positives for HPV-16 oncoproteins. Biochem Biophys Res Commun 2000, 277:55-61. 10.1006/bbrc.2000.3628, 11027639.
8. Kyo S, Inoue M, Hayasaka N, Inoue T, Yutsudo M, Tanizawa O, Hakura A. Regulation of early gene expression of human papillomavirus type 16 by inflammatory cytokines. Virology 1994, 200:130-139. 10.1006/viro.1994.1171, 8128617.
9. Basile JR, Zacny V, Munger K. The cytokines tumor necrosis factor-alpha (TNF-alpha) and TNF-related apoptosis-inducing ligand differentially modulate proliferation and apoptotic pathways in human keratinocytes expressing the human papillomavirus-16 E7 oncoprotein. J Biol Chem 2001, 276:22522-22528. 10.1074/jbc.M010505200, 11306566.
10. Malejczyk J, Malejczyk M, Kock A, Urbanski A, Majewski S, Hunzelmann N, Jablonska S, Orth G, Luger TA. Autocrine growth limitation of human papillomavirus type 16-harboring keratinocytes by constitutively released tumor necrosis factor-alpha. J Immunol 1992, 149:2702-2708.
11. Trimble CL, Clark RA, Thoburn C, Hanson NC, Tassello J, Frosina D, Kos F, Teague J, Jiang Y, Barat NC, Jungbluth AA. Human papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epithelium. J Immunol 2010, 185:7107-7114. 10.4049/jimmunol.1002756, 3075978, 21037100.
12. James MA, Lee JH, Klingelhutz AJ. Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner. J Virol 2006, 80:5301-5307. 10.1128/JVI.01942-05, 1472131, 16699010.
13. Woodworth CD, McMullin E, Iglesias M, Plowman GD. Interleukin 1 alpha and tumor necrosis factor alpha stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells. Proc Natl Acad Sci USA 1995, 92:2840-2844. 10.1073/pnas.92.7.2840, 42314, 7708734.
14. Gaiotti D, Chung J, Iglesias M, Nees M, Baker PD, Evans CH, Woodworth CD. Tumor necrosis factor-alpha promotes human papillomavirus (HPV) E6/E7 RNA expression and cyclin-dependent kinase activity in HPV-immortalized keratinocytes by a ras-dependent pathway. Mol Carcinog 2000, 27:97-109. 10.1002/(SICI)1098-2744(200002)27:2<97::AID-MC5>3.0.CO;2-V, 10657902.
15. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997, 94:3195-3199. 10.1073/pnas.94.7.3195, 20345, 9096369.
16. Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, Itoh K. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 1998, 51:605-612. 10.1111/j.1399-0039.1998.tb03002.x, 9694352.
17. Deshpande A, Nolan JP, White PS, Valdez YE, Hunt WC, Peyton CL, Wheeler CM. TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer. J Infect Dis 2005, 191:969-976. 10.1086/427826, 15717274.
18. Garrity-Park MM, Loftus EV, Bryant SC, Sandborn WJ, Smyrk TC. Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer. Am J Gastroenterol 2008, 103:407-415. 10.1111/j.1572-0241.2007.01572.x, 18289203.
19. Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, Smith MT, Spinelli JJ, Willett E, De Sanjose S, Cocco P, et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 2006, 7:27-38. 10.1016/S1470-2045(05)70434-4, 16389181.
20. Yang CM, Hou YY, Chiu YT, Chen HC, Chu ST, Chi CC, Hsiao M, Lee CY, Hsieh CJ, Lin YC, et al. Interaction between tumour necrosis factor-alpha gene polymorphisms and substance use on risk of betel quid-related oral and pharyngeal squamous cell carcinoma in Taiwan. Arch Oral Biol 2011, 56:1162-1169. 10.1016/j.archoralbio.2011.03.009, 21497332.
21. Correa GT, Bandeira GA, Cavalcanti BG, de Carvalho Fraga CA, dos Santos EP, Silva TF, Gomez RS, Guimaraes AL, De Paula AM. Association of -308 TNF-alpha promoter polymorphism with clinical aggressiveness in patients with head and neck squamous cell carcinoma. Oral Oncol 2011, 47:888-894. 10.1016/j.oraloncology.2011.07.001, 21788151.
22. Gupta R, Sharma SC, Das SN. Association of TNF-alpha and TNFR1 promoters and 3′ UTR region of TNFR2 gene polymorphisms with genetic susceptibility to tobacco-related oral carcinoma in Asian Indians. Oral Oncol 2008, 44:455-463. 10.1016/j.oraloncology.2007.06.003, 18206417.
23. Kietthubthew S, Wickliffe J, Sriplung H, Ishida T, Chonmaitree T, Au WW. Association of polymorphisms in proinflammatory cytokine genes with the development of oral cancer in Southern Thailand. Int J Hyg Environ Health 2010, 213:146-152. 10.1016/j.ijheh.2010.01.002, 20133197.
24. Vairaktaris E, Yapijakis C, Serefoglou Z, Avgoustidis D, Critselis E, Spyridonidou S, Vylliotis A, Derka S, Vassiliou S, Nkenke E, Patsouris E. Gene expression polymorphisms of interleukins-1 beta, -4, -6, -8, -10, and tumor necrosis factors-alpha, -beta: regression analysis of their effect upon oral squamous cell carcinoma. J Cancer Res Clin Oncol 2008, 134:821-832. 10.1007/s00432-008-0360-z, 18273643.
25. Yapijakis C, Serefoglou Z, Vylliotis A, Nkenke E, Derka S, Vassiliou S, Avgoustidis D, Neukam FW, Patsouris E, Vairaktaris E. Association of polymorphisms in Tumor Necrosis Factor Alpha and Beta genes with increased risk for oral cancer. Anticancer Res 2009, 29:2379-2386.
26. Liu CJ, Wong YK, Chang KW, Chang HC, Liu HF, Lee YJ. Tumor necrosis factor-alpha promoter polymorphism is associated with susceptibility to oral squamous cell carcinoma. J Oral Pathol Med 2005, 34:608-612. 10.1111/j.1600-0714.2005.00359.x, 16202081.
27. Wang Z, Sturgis EM, Zhang Y, Huang Z, Zhou Q, Wei Q, Li G. Combined p53-related genetic variants together with HPV infection increase oral cancer risk. Int J Cancer 2012, 131:E251-258. 10.1002/ijc.27335, 22052649.
28. Dahlstrom KR, Adler-Storthz K, Etzel CJ, Liu Z, Dillon L, El-Naggar AK, Spitz MR, Schiller JT, Wei Q, Sturgis EM. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res 2003, 9:2620-2626.
29. Kohaar I, Thakur N, Salhan S, Batra S, Singh V, Sharma A, Sodhani P, Das BC, Sarkar DP, Bharadwaj M. TNFalpha-308G/A polymorphism as a risk factor for HPV associated cervical cancer in Indian population. Cell Oncol 2007, 29:249-256.
30. Ding B, Fu S, Wang M, Yue C, Wang W, Zhou D, Zhang Z, Han S. Tumor necrosis factor alpha -308 G > A polymorphisms and cervical cancer risk: a meta-analysis. Int J Gynecol Cancer 2012, 22:213-219. 10.1097/IGC.0b013e3182375aed, 22146770.
31. Applebaum KM, Furniss CS, Zeka A, Posner MR, Smith JF, Bryan J, Eisen EA, Peters ES, McClean MD, Kelsey KT. Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. J Natl Cancer Inst 2007, 99:1801-1810. 10.1093/jnci/djm233, 18042931.